Emerging roles of growth differentiation factor‑15 in brain disorders (Review)
- Authors:
- Wei-Wei Jiang
- Zi-Zhen Zhang
- Ping-Ping He
- Li-Ping Jiang
- Jin-Zhi Chen
- Xing-Ting Zhang
- Mi Hu
- Yang-Kai Zhang
- Xin-Ping Ouyang
-
Affiliations: Department of Physiology, Institute of Neuroscience Research, Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Medical Humanities, School of Medicine, Hunan Polytechnic of Environment and Biology, Hengyang, Hunan 421001, P.R. China, Hunan Province Cooperative Innovation Centre for Molecular Target New Drug Study, Nursing School, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: September 7, 2021 https://doi.org/10.3892/etm.2021.10705
- Article Number: 1270
-
Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Raggi A and Leonardi M: Burden of brain disorders in Europe in 2017 and comparison with other non-communicable disease groups. J Neurol Neurosurg Psychiatry. 91:104–105. 2020.PubMed/NCBI View Article : Google Scholar | |
Bautista-Aguilera OM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J and Pérez M: Tacrines as therapeutic agents for alzheimer's disease. V. recent developments. Chem Rec. 21:162–174. 2021.PubMed/NCBI View Article : Google Scholar | |
Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, et al: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA. 94:11514–11519. 1997.PubMed/NCBI View Article : Google Scholar | |
Yokoyama-Kobayashi M, Saeki M, Sekine S and Kato S: Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. J Biochem. 122:622–626. 1997.PubMed/NCBI View Article : Google Scholar | |
Bottner M, Laaff M, Schechinger B, Rappold G, Unsicker K and Suter-Crazzolara C: Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene. 237:105–111. 1999.PubMed/NCBI View Article : Google Scholar | |
Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban RH, et al: Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res. 10:2386–2392. 2004.PubMed/NCBI View Article : Google Scholar | |
Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, Yaghoutyfam N, Marquis CP, Stattin P, Pedersen NL, et al: Macrophage inhibitory cytokine-1 (MIC-1/GDF15): A new marker of all-cause mortality. Aging Cell. 9:1057–1064. 2010.PubMed/NCBI View Article : Google Scholar | |
Conte M, Martucci M, Chiariello A, Franceschi C and Salvioli S: Mitochondria, immunosenescence and inflammaging: A role for mitokines? Semin Immunopathol. 42:607–617. 2020.PubMed/NCBI View Article : Google Scholar | |
Rochette L, Zeller M, Cottin Y and Vergely C: Insights into mechanisms of GDF15 and receptor GFRAL: Therapeutic targets. Trends Endocrinol Metab. 31:939–951. 2020.PubMed/NCBI View Article : Google Scholar | |
Kang YE, Kim JM, Lim MA, Lee SE, Yi S, Kim JT, Oh C, Liu L, Jin Y, Jung SN, et al: Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness. Thyroid. 31:772–786. 2021.PubMed/NCBI View Article : Google Scholar | |
Nakayasu ES, Syed F, Tersey SA, Gritsenko MA, Mitchell HD, Chan CY, Dirice E, Turatsinze JV, Cui Y, Kulkarni RN, et al: Comprehensive proteomics analysis of stressed human islets identifies GDF15 as a target for type 1 diabetes intervention. Cell Metab. 31:363–374.e6. 2020.PubMed/NCBI View Article : Google Scholar | |
Wang Y, Zhen C, Wang R and Wang G: Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis. Am J Emerg Med. 37:1346–1352. 2019.PubMed/NCBI View Article : Google Scholar | |
Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjær SB, Wu X, Huang T, Hultman K, Paulsen SJ, et al: GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 23:1158–1166. 2017.PubMed/NCBI View Article : Google Scholar | |
Mullican SE, Lin-Schmidt X, Chin CN, Chavez JA, Furman JL, Armstrong AA, Beck SC, South VJ, Dinh TQ, Cash-Mason TD, et al: GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 23:1150–1157. 2017.PubMed/NCBI View Article : Google Scholar | |
Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, Kutach A, Joo W, Gao Z, Fu D, et al: Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 550:255–259. 2017.PubMed/NCBI View Article : Google Scholar | |
Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, et al: The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 23:1215–1219. 2017.PubMed/NCBI View Article : Google Scholar | |
Borner T, Shaulson ED, Ghidewon MY, Barnett AB, Horn CC, Doyle RP, Grill HJ, Hayes MR and De Jonghe BC: GDF15 induces anorexia through Nausea and Emesis. Cell Metab. 31:351–362.e5. 2020.PubMed/NCBI View Article : Google Scholar | |
Klaus S, Igual Gil C and Ost M: Regulation of diurnal energy balance by mitokines. Cell Mol Life Sci. 78:3369–3384. 2021.PubMed/NCBI View Article : Google Scholar | |
Kim DH, Lee D, Lim H, Choi SJ, Oh W, Yang YS, Chang JH and Jeon HB: Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease. Biochem Biophys Res Commun. 504:933–940. 2018.PubMed/NCBI View Article : Google Scholar | |
Kostuk EW, Cai J and Iacovitti L: Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture. Glia. 67:1542–1557. 2019.PubMed/NCBI View Article : Google Scholar | |
Breniere C, Meloux A, Pedard M, Marie C, Thouant P, Vergely C and Béjot Y: Growth differentiation factor-15 (GDF-15) is associated with mortality in ischemic stroke patients treated with acute revascularization therapy. Front Neurol. 10(611)2019.PubMed/NCBI View Article : Google Scholar | |
Li S, Wang Y, Cao B, Wu Y, Ji L, Li YX, Liu M, Zhao Y, Qiao J, Wang H, et al: Maturation of growth differentiation factor 15 in human placental trophoblast cells depends on the interaction with Matrix Metalloproteinase-26. J Clin Endocrinol Metab. 99:E2277–E2287. 2014.PubMed/NCBI View Article : Google Scholar | |
Couture F, Sabbagh R, Kwiatkowska A, Desjardins R, Guay SP, Bouchard L and Day R: PACE4 undergoes an oncogenic alternative splicing switch in cancer. Cancer Res. 77:6863–6879. 2017.PubMed/NCBI View Article : Google Scholar | |
Fairlie WD, Russell PK, Wu WM, Moore AG, Zhang HP, Brown PK, Bauskin AR and Breit SN: Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): Identification of at least five distinct epitope specificities. Biochemistry. 40:65–73. 2001.PubMed/NCBI View Article : Google Scholar | |
Bauskin AR, Zhang HP, Fairlie WD, He XY, Russell PK, Moore AG, Brown DA, Stanley KK and Breit SN: The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J. 19:2212–2220. 2000.PubMed/NCBI View Article : Google Scholar | |
Bauskin AR, Jiang L, Luo XW, Wu L, Brown DA and Breit SN: The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores. J Interferon Cytokine Res. 30:389–397. 2010.PubMed/NCBI View Article : Google Scholar | |
Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, et al: The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome. Cancer Res. 65:2330–2336. 2005.PubMed/NCBI View Article : Google Scholar | |
Tsai VWW, Husaini Y, Sainsbury A, Brown DA and Breit SN: The MIC-1/GDF15-GFRAL pathway in energy homeostasis: Implications for obesity, cachexia, and other associated diseases. Cell Metab. 28:353–368. 2018.PubMed/NCBI View Article : Google Scholar | |
Wollert KC, Kempf T and Wallentin L: Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem. 63:140–151. 2017.PubMed/NCBI View Article : Google Scholar | |
Demir O, Barros EP, Offutt TL, Rosenfeld M and Amaro RE: An integrated view of p53 dynamics, function, and reactivation. Curr Opin Struct Biol. 67:187–194. 2021.PubMed/NCBI View Article : Google Scholar | |
Tan M, Wang Y, Guan K and Sun Y: PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA. 97:109–114. 2000.PubMed/NCBI View Article : Google Scholar | |
Kannan K, Amariglio N, Rechavi G and Givol D: Profile of gene expression regulated by induced p53: Connection to the TGF-beta family. FEBS Lett. 470:77–82. 2000.PubMed/NCBI View Article : Google Scholar | |
Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC and Klamut HJ: Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem. 275:20127–20135. 2000.PubMed/NCBI View Article : Google Scholar | |
Yang H, Filipovic Z, Brown D, Breit SN and Vassilev LT: Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation. Mol Cancer Ther. 2:1023–1029. 2003.PubMed/NCBI | |
Tiwari KK, Moorthy B and Lingappan K: Role of GDF15 (growth and differentiation factor 15) in pulmonary oxygen toxicity. Toxicol In Vitro. 29:1369–1376. 2015.PubMed/NCBI View Article : Google Scholar | |
Kim Y, Noren Hooten N and Evans MK: CRP stimulates GDF15 expression in endothelial cells through p53. Mediators Inflamm. 2018(8278039)2018.PubMed/NCBI View Article : Google Scholar | |
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.PubMed/NCBI View Article : Google Scholar | |
Osada M, Park HL, Park MJ, Liu JW, Wu G, Trink B and Sidransky D: A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun. 354:913–918. 2007.PubMed/NCBI View Article : Google Scholar | |
Pagel JI and Deindl E: Disease progression mediated by egr-1 associated signaling in response to oxidative stress. Int J Mol Sci. 13:13104–13117. 2012.PubMed/NCBI View Article : Google Scholar | |
Baek SJ, Kim JS, Nixon JB, DiAugustine RP and Eling TE: Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem. 279:6883–6892. 2004.PubMed/NCBI View Article : Google Scholar | |
Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J and Eling TE: Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the upregulation of NAG-1, an antitumorigenic protein. Mol Pharmacol. 67:356–364. 2005.PubMed/NCBI View Article : Google Scholar | |
Chintharlapalli S, Papineni S, Baek SJ, Liu S and Safe S: 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1. Mol Pharmacol. 68:1782–1792. 2005.PubMed/NCBI View Article : Google Scholar | |
Kadowaki M, Yoshioka H, Kamitani H, Watanabe T, Wade PA and Eling TE: DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. Int J Cancer. 130:267–277. 2012.PubMed/NCBI View Article : Google Scholar | |
Woo SM, Min KJ, Kim S, Park JW, Kim DE, Chun KS, Kim YH, Lee TJ, Kim SH, Choi YH, et al: Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) upregulation. Chem Biol Interact. 211:36–43. 2014.PubMed/NCBI View Article : Google Scholar | |
Statello L, Guo CJ, Chen LL and Huarte M: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 22:96–118. 2021.PubMed/NCBI View Article : Google Scholar | |
Kong J, Sun W, Zhu W, Liu C, Zhang H and Wang H: Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15. J Surg Oncol. 118:1326–1334. 2018.PubMed/NCBI View Article : Google Scholar | |
Xiong X, Yuan J, Zhang N, Zheng Y, Liu J and Yang M: Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis. Biochem Biophys Res Commun. 521:478–484. 2020.PubMed/NCBI View Article : Google Scholar | |
Guo LL and Wang SF: Downregulated long noncoding RNA GAS5 fails to function as decoy of CEBPB, resulting in increased GDF15 expression and rapid ovarian cancer cell proliferation. Cancer Biother Radiopharm. 34:537–546. 2019.PubMed/NCBI View Article : Google Scholar | |
Liu B, Li J and Cairns MJ: Identifying miRNAs, targets and functions. Brief Bioinform. 15:1–19. 2014.PubMed/NCBI View Article : Google Scholar | |
Teng MS, Hsu LA, Juan SH, Lin WC, Lee MC, Su CW, Wu S and Ko YL: A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p. PLoS One. 12(e0183187)2017.PubMed/NCBI View Article : Google Scholar | |
Jones MF, Li XL, Subramanian M, Shabalina SA, Hara T, Zhu Y, Huang J, Yang Y, Wakefield LM, Prasanth KV and Lal A: Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death. Cell Death Differ. 22:1641–1653. 2015.PubMed/NCBI View Article : Google Scholar | |
Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, Cimino I, Yang M, Welsh P, Virtue S, et al: GDF15 mediates the effects of metformin on body weight and energy balance. Nature. 578:444–448. 2020.PubMed/NCBI View Article : Google Scholar | |
Melvin A, Chantzichristos D, Kyle CJ, Mackenzie SD, Walker BR, Johannsson G, Stimson RH and O'Rahilly S: GDF15 is elevated in conditions of glucocorticoid deficiency and is modulated by glucocorticoid replacement. J Clin Endocrinol Metab. 105:1427–1434. 2020.PubMed/NCBI View Article : Google Scholar | |
Campderros L, Moure R, Cairo M, Gavaldà-Navarro A, Quesada-López T, Cereijo R, Giralt M, Villarroya J and Villarroya F: Brown Adipocytes Secrete GDF15 in response to thermogenic activation. Obesity (Silver Spring). 27:1606–1616. 2019.PubMed/NCBI View Article : Google Scholar | |
Zhao J, Li M, Chen Y, Zhang S, Ying H, Song Z, Lu Y, Li X, Xiong X and Jiang J: Elevated serum growth differentiation Factor 15 levels in hyperthyroid patients. Front Endocrinol (Lausanne). 9(793)2019.PubMed/NCBI View Article : Google Scholar | |
Liu H, Dai W, Cui Y, Lyu Y and Li Y: Potential associations of circulating growth differentiation factor-15 with sex hormones in male patients with coronary artery disease. Biomed Pharmacother. 114(108792)2019.PubMed/NCBI View Article : Google Scholar | |
Ha G, De Torres F, Arouche N, Benzoubir N, Ferratge S, Hatem E, Anginot A and Uzan G: GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions. PLoS One. 14(e0216602)2019.PubMed/NCBI View Article : Google Scholar | |
Jin YJ, Lee JH, Kim YM, Oh GT and Lee H: Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Cell Signal. 24:1485–1495. 2012.PubMed/NCBI View Article : Google Scholar | |
Song H, Yin D and Liu Z: GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells. Mol Biol Rep. 39:4017–4022. 2012.PubMed/NCBI View Article : Google Scholar | |
Wang S, Li M, Zhang W, Hua H, Wang N, Zhao J, Ge J, Jiang X, Zhang Z, Ye D and Yang C: Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect. Sci Rep. 7(9027)2017.PubMed/NCBI View Article : Google Scholar | |
Lugano R, Ramachandran M and Dimberg A: Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 77:1745–1770. 2020.PubMed/NCBI View Article : Google Scholar | |
Dong G, Zheng QD, Ma M, Wu SF, Zhang R, Yao RR, Dong YY, Ma H, Gao DM, Ye SL, et al: Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15. Cancer Med. 7:820–830. 2018.PubMed/NCBI View Article : Google Scholar | |
Whitson RJ, Lucia MS and Lambert JR: Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2). J Cell Biochem. 114:1424–1433. 2013.PubMed/NCBI View Article : Google Scholar | |
Kist M and Vucic D: Cell death pathways: Intricate connections and disease implications. EMBO J. 40(e106700)2021.PubMed/NCBI View Article : Google Scholar | |
Zhu S, Yang N, Guan Y, Wang X, Zang G, Lv X, Deng S, Wang W, Li T and Chen J: GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2-c-Fos-LIF signaling. Cell Death Discov. 7(3)2021.PubMed/NCBI View Article : Google Scholar | |
Zhang W, Hu C, Wang X, Bai S, Cao S, Kobelski M, Lambert JR, Gu J and Zhan Y: Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. PLoS One. 14(e0222812)2019.PubMed/NCBI View Article : Google Scholar | |
Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ and Breit SN: Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res. 63:5034–5040. 2003.PubMed/NCBI | |
Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J and Kinscherf R: Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res. 318:325–333. 2004.PubMed/NCBI View Article : Google Scholar | |
Tarfiei GA, Shadboorestan A, Montazeri H, Rahmanian N, Tavosi G and Ghahremani MH: GDF15 induced apoptosis and cytotoxicity in A549 cells depends on TGFBR2 expression. Cell Biochem Funct. 37:320–330. 2019.PubMed/NCBI View Article : Google Scholar | |
Li J, Yang L, Qin W, Zhang G, Yuan J and Wang F: Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus. PLoS One. 8(e65549)2013.PubMed/NCBI View Article : Google Scholar | |
Nickel N, Jonigk D, Kempf T, Bockmeyer CL, Maegel L, Rische J, Laenger F, Lehmann U, Sauer C, Greer M, et al: GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells. Respir Res. 12(62)2011.PubMed/NCBI View Article : Google Scholar | |
Suriben R, Chen M, Higbee J, Oeffinger J, Ventura R, Li B, Mondal K, Gao Z, Ayupova D, Taskar P, et al: Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat Med. 26:1264–1270. 2020.PubMed/NCBI View Article : Google Scholar | |
Chrysovergis K, Wang X, Kosak J, Lee SH, Kim JS, Foley JF, Travlos G, Singh S, Baek SJ and Eling TE: NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond). 38:1555–1564. 2014.PubMed/NCBI View Article : Google Scholar | |
Tsai VW, Zhang HP, Manandhar R, Schofield P, Christ D, Lee-Ng KKM, Lebhar H, Marquis CP, Husaini Y, Brown DA and Breit SN: GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS. Int J Obes (Lond). 43:2370–2380. 2019.PubMed/NCBI View Article : Google Scholar | |
Zhang Z, Xu X, Tian W, Jiang R, Lu Y, Sun Q, Fu R, He Q, Wang J, Liu Y, et al: ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. J Hepatol. 72:976–989. 2020.PubMed/NCBI View Article : Google Scholar | |
Zhang M, Sun W, Qian J and Tang Y: Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver. Redox Biol. 16:87–96. 2018.PubMed/NCBI View Article : Google Scholar | |
Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, Herzog EL, Kang I, Pisani MA, Yu S, et al: GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell. 178:1231–1244.e11. 2019.PubMed/NCBI View Article : Google Scholar | |
Wu Q, Jiang D, Schaefer NR, Harmacek L, O'Connor BP, Eling TE, Eickelberg O and Chu HW: Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung. Am J Physiol Lung Cell Mol Physiol. 314:L514–L527. 2018.PubMed/NCBI View Article : Google Scholar | |
Abulizi P, Loganathan N, Zhao D, Mele T, Zhang Y, Zwiep T, Liu K and Zheng X: Growth differentiation factor-15 deficiency augments inflammatory response and exacerbates septic heart and renal injury induced by lipopolysaccharide. Sci Rep. 7(1037)2017.PubMed/NCBI View Article : Google Scholar | |
Li A, Zhao F, Zhao Y, Liu H and Wang Z: ATF4-mediated GDF15 suppresses LPS-induced inflammation and MUC5AC in human nasal epithelial cells through the PI3K/Akt pathway. Life Sci. 275(119356)2021.PubMed/NCBI View Article : Google Scholar | |
Li M, Song K, Huang X, Fu S and Zeng Q: GDF15 prevents LPS and D-galactosamine-induced inflammation and acute liver injury in mice. Int J Mol Med. 42:1756–1764. 2018.PubMed/NCBI View Article : Google Scholar | |
Hu X, Wang T and Jin F: Alzheimer's disease and gut microbiota. Sci China Life Sci. 59:1006–1023. 2016.PubMed/NCBI View Article : Google Scholar | |
Chen YG: Research progress in the pathogenesis of Alzheimer's disease. Chin Med J (Engl). 131:1618–1624. 2018.PubMed/NCBI View Article : Google Scholar | |
Strelau J, Sullivan A, Bottner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K and Unsicker K: Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci. 20:8597–8603. 2000.PubMed/NCBI View Article : Google Scholar | |
Schober A, Bottner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN and Unsicker K: Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol. 439:32–45. 2001.PubMed/NCBI View Article : Google Scholar | |
Fuchs T, Trollor JN, Crawford J, Brown DA, Baune BT, Samaras K, Campbell L, Breit SN, Brodaty H, Sachdev P and Smith E: Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline-the Sydney memory and aging study. Aging Cell. 12:882–889. 2013.PubMed/NCBI View Article : Google Scholar | |
Chai YL, Hilal S, Chong JPC, Ng YX, Liew OW, Xu X, Ikram MK, Venketasubramanian N, Richards AM, Lai MKP and Chen CP: Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine (Baltimore). 95(e4566)2016.PubMed/NCBI View Article : Google Scholar | |
Low JK, Ambikairajah A, Shang K, Brown DA, Tsai VW, Breit SN and Karl T: First behavioural characterisation of a knockout mouse model for the transforming growth factor (TGF)-β superfamily cytokine, MIC-1/GDF15. PLoS One. 12(e0168416)2017.PubMed/NCBI View Article : Google Scholar | |
Nasrabady SE, Rizvi B, Goldman JE and Brickman AM: White matter changes in Alzheimer's disease: A focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 6(22)2018.PubMed/NCBI View Article : Google Scholar | |
Jiang J, Trollor JN, Brown DA, Crawford JD, Thalamuthu A, Smith E, Breit SN, Liu T, Brodaty H, Baune BT, et al: An inverse relationship between serum macrophage inhibitory cytokine-1 levels and brain white matter integrity in community-dwelling older individuals. Psychoneuroendocrinology. 62:80–88. 2015.PubMed/NCBI View Article : Google Scholar | |
Jiang J, Wen W, Brown DA, Crawford J, Thalamuthu A, Smith E, Breit SN, Liu T, Zhu W, Brodaty H, et al: The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals. PLoS One. 10(e0123399)2015.PubMed/NCBI View Article : Google Scholar | |
Mu Y and Gage FH: Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener. 6(85)2011.PubMed/NCBI View Article : Google Scholar | |
Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F, Altick AL, von Bartheld CS, Klein R, Sendtner M and Unsicker K: Progressive postnatal motoneuron loss in mice lacking GDF-15. J Neurosci. 29:13640–13648. 2009.PubMed/NCBI View Article : Google Scholar | |
Carrillo-Garcia C, Prochnow S, Simeonova IK, Strelau J, Hölzl-Wenig G, Mandl C, Unsicker K, von Bohlen Und Halbach O and Ciccolini F: Growth/differentiation factor 15 promotes EGFR signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice. Development. 141:773–783. 2014.PubMed/NCBI View Article : Google Scholar | |
Kim DH, Lee D, Chang EH, Kim JH, Hwang JW, Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, et al: GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model. Stem Cells Dev. 24:2378–2390. 2015.PubMed/NCBI View Article : Google Scholar | |
Sudhof TC: Molecular neuroscience in the 21st Century: A personal perspective. Neuron. 96:536–541. 2017.PubMed/NCBI View Article : Google Scholar | |
Liu DD, Lu JM, Zhao QR, Hu C and Mei YA: Growth differentiation factor-15 promotes glutamate release in medial prefrontal cortex of mice through upregulation of T-type calcium channels. Sci Rep. 6(28653)2016.PubMed/NCBI View Article : Google Scholar | |
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D and Jones E: Alzheimer's disease. Lancet. 377:1019–1031. 2011.PubMed/NCBI View Article : Google Scholar | |
Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, et al: Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest. 116:3060–3069. 2006.PubMed/NCBI View Article : Google Scholar | |
Das P and Golde T: Dysfunction of TGF-beta signaling in Alzheimer's disease. J Clin Invest. 116:2855–2857. 2006.PubMed/NCBI View Article : Google Scholar | |
Koh SH and Park HH: Neurogenesis in stroke recovery. Transl Stroke Res. 8:3–13. 2017.PubMed/NCBI View Article : Google Scholar | |
Barthels D and Das H: Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 1866(165260)2020.PubMed/NCBI View Article : Google Scholar | |
Xiang Y, Zhang T, Guo J, Peng YF and Wei YS: The association of growth differentiation factor-15 gene polymorphisms with growth differentiation factor-15 serum levels and risk of ischemic stroke. J Stroke Cerebrovasc Dis. 26:2111–2119. 2017.PubMed/NCBI View Article : Google Scholar | |
Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T and Ridker PM: Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: A nested case-control study. Lancet. 359:2159–2163. 2002.PubMed/NCBI View Article : Google Scholar | |
Worthmann H, Kempf T, Widera C, Tryc AB, Goldbecker A, Ma YT, Deb M, Tountopoulou A, Lambrecht J, Heeren M, et al: Growth differentiation factor 15 plasma levels and outcome after ischemic stroke. Cerebrovasc Dis. 32:72–78. 2011.PubMed/NCBI View Article : Google Scholar | |
Yin J, Zhu Z, Guo D, Wang A, Zeng N, Zheng X, Peng Y, Zhong C, Wang G, Zhou Y, et al: Increased growth differentiation factor 15 is associated with unfavorable clinical outcomes of acute ischemic stroke. Clin Chem. 65:569–578. 2019.PubMed/NCBI View Article : Google Scholar | |
Groschel K, Schnaudigel S, Edelmann F, Niehaus CF, Weber-Krüger M, Haase B, Lahno R, Seegers J, Wasser K, Wohlfahrt J, et al: Growth-differentiation factor-15 and functional outcome after acute ischemic stroke. J Neurol. 259:1574–1579. 2012.PubMed/NCBI View Article : Google Scholar | |
Dong X and Nao J: Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population. Int J Neurosci. 129:1247–1255. 2019.PubMed/NCBI View Article : Google Scholar | |
Wang X, Zhu L, Wu Y, Sun K, Su M, Yu L, Chen J, Li W, Yang J, Yuan Z and Hui R: Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients. Medicine (Baltimore). 95(e4342)2016.PubMed/NCBI View Article : Google Scholar | |
Schindowski K, von Bohlen und Halbach O, Strelau J, Ridder DA, Herrmann O, Schober A, Schwaninger M and Unsicker K: Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia. Cell Tissue Res. 343:399–409. 2011.PubMed/NCBI View Article : Google Scholar | |
Dickson DW: Neuropathology of Parkinson disease. Parkinsonism Relat Disord. 46 (Suppl 1):S30–S33. 2018.PubMed/NCBI View Article : Google Scholar | |
Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH and Halliday G: Missing pieces in the Parkinson's disease puzzle. Nat Med. 16:653–661. 2010.PubMed/NCBI View Article : Google Scholar | |
Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW, Roncoroni L, Schaeffer E, et al: GDF15/MIC1 and MMP9 cerebrospinal fluid levels in Parkinson's disease and lewy body dementia. PLoS One. 11(e0149349)2016.PubMed/NCBI View Article : Google Scholar | |
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The unified Parkinson's disease rating scale (UPDRS): Status and recommendations. Mov Disord. 18:738–750. 2003.PubMed/NCBI View Article : Google Scholar | |
Yao X, Wang D, Zhang L, Wang L, Zhao Z, Chen S, Wang X, Yue T and Liu Y: Serum growth differentiation factor 15 in Parkinson disease. Neurodegener Dis. 17:251–260. 2017.PubMed/NCBI View Article : Google Scholar | |
Luthman J, Fredriksson A, Sundstrom E, Jonsson G and Archer T: Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: Motor behavior and monoamine alterations at adult stage. Behav Brain Res. 33:267–277. 1989.PubMed/NCBI View Article : Google Scholar | |
Machado V, Haas SJ, von Bohlen Und Halbach O, Wree A, Krieglstein K, Unsicker K and Spittau B: Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis. 88:1–15. 2016.PubMed/NCBI View Article : Google Scholar | |
Machado V, Gilsbach R, Das R, Schober A, Bogatyreva L, Hauschke D, Krieglstein K, Unsicker K and Spittau B: Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice. Cell Tissue Res. 365:209–223. 2016.PubMed/NCBI View Article : Google Scholar | |
Hirsch E, Graybiel AM and Agid YA: Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 334:345–348. 1988.PubMed/NCBI View Article : Google Scholar | |
Liu H, Liu J, Si L, Guo C, Liu W and Liu Y: GDF-15 promotes mitochondrial function and proliferation in neuronal HT22 cells. J Cell Biochem. 120:10530–10547. 2019.PubMed/NCBI View Article : Google Scholar | |
Miyaue N, Yabe H and Nagai M: Serum growth differentiation factor 15, but not lactate, is elevated in patients with Parkinson's disease. J Neurol Sci. 409(116616)2020.PubMed/NCBI View Article : Google Scholar |